Discovery of Novel Human Breast Cancer MicroRNAs from Deep Sequencing Data by Analysis of Pri-MicroRNA Secondary Structures
2011

Discovery of Novel Human Breast Cancer MicroRNAs from Deep Sequencing

Sample size: 3 publication Evidence: high

Author Information

Author(s): Ryu Seongho, Joshi Natasha, McDonnell Kevin, Woo Jongchan, Choi Hyejin, Gao Dingcheng, McCombie William R., Mittal Vivek

Primary Institution: Weill Cornell Medical College of Cornell University

Hypothesis

Can deep sequencing technology identify novel microRNAs in human breast cancer cell lines?

Conclusion

The study successfully identified 189 candidate novel microRNAs in human breast cancer cell lines using deep sequencing.

Supporting Evidence

  • The study identified 189 candidate novel microRNAs in human breast cancer cell lines.
  • The analysis of pri-microRNA secondary structure was shown to predict bona fide miRNAs with approximately 90% accuracy.
  • Experimental validation confirmed that only some of the predicted candidates were expressed as mature miRNAs.

Takeaway

Scientists found new tiny molecules called microRNAs that might help us understand breast cancer better by using a special sequencing technique.

Methodology

Deep sequencing technology was used to analyze RNA from breast cancer cell lines, identifying novel microRNAs based on their secondary structures.

Limitations

The sensitivity of northern blotting may not be sufficient to detect lowly expressed miRNAs.

Participant Demographics

Human breast cancer cell lines MCF10A (nontumorigenic), MCF7 (tumorigenic, nonmetastatic), and MDA-MB-231 (tumorigenic, metastatic).

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1371/journal.pone.0016403

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication